Lumenis Ltd, together with its subsidiaries, develops and commercializes energy-based medical systems. The company operates in three segments: Surgical, Ophthalmic, and Aesthetic. The Surgical segment offers various surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices. The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology departments of hospitals, primarily for use ...
Yokneam Industrial Park
PO Box 240
Founded in 1991
Lumenis Ltd. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Revises Earnings Guidance for the Full Year Ending December 31, 2014
Nov 11 14
Lumenis Ltd. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. Total revenue in the third quarter of 2014 was $74.2 million, an increase of 9.4% compared to revenue of $67.8 million last year. On a constant currency basis, total revenue increased 10% year-over-year. Total revenue growth was driven by growth in Aesthetics and Surgical segments, partially offset by declines in Ophthalmic segment. Third quarter 2014 GAAP operating income was $7.1 million, an increase of $0.5 million, or 8.4%, compared to GAAP operating income of $6.6 million last year. Third quarter 2014 GAAP net income was $5.5 million, an increase of $2.1 million, compared to $3.4 million last year. GAAP net income per diluted share was $0.15 in the third quarter of 2014 compared to $0.11 last year, based on 35.8 million and 30.0 million diluted shares outstanding respectively. Third quarter 2014 non-GAAP operating income was $8.0 million, an increase of $0.8 million, or 11.7%, compared to non-GAAP operating income of $7.2 million last year. Third quarter 2014 adjusted EBITDA was $10.2 million, an increase of $1.5 million, or 16.4%, compared to $8.7 million last year. Third quarter 2014 non-GAAP net income was $6.0 million, an increase of $0.3 million, or 4.2%, compared to $5.7 million last year. Non-GAAP net income per diluted share was $0.17 in the third quarter of 2014 compared to $0.19 last year based on 35.8 million and 30.2 million diluted shares outstanding respectively. Net cash provided by operating activities was $2,537,000 against $6,604,000 a year ago. Purchase of property and equipment was $893,000 against $1,039,000 a year ago.
For the nine months, total revenues were $212,487,000, operating income was $13,830,000 and net income was $5,905,000 or $0.17 per diluted share against total revenues of $194,262,000, operating income of $19,314,000 and net income of $12,691,000 or $0.43 per diluted share a year ago. Net cash provided by operating activities was $5,556,000 against $23,271,000 a year ago. Purchase of property and equipment was $3,049,000 against $2,549,000 a year ago. Non GAAP operating income was $17,383,000 against $13,872,000 a year ago. Adjusted EBITDA was $22,704,000 against $18,116,000 a year ago. Non-GAAP net income was $12,860,000 or $0.37 per diluted share against $9,430,000 or $0.32 per diluted share a year ago.
For the full year ending December 31, 2014, the company expects to report: Revenue in a range of $285 to $287 million, representing an increase of 7% to 8% year-over-year. This compares to a range of $284 million to $287 million previously. Adjusted EBITDA in a range of $29.6 to $30.6 million, representing an increase of 14% to 18% year-over-year. This compares to a range of $29.1 million to $30.6 million previously. Non-GAAP net income in a range of $18.1 to $19.6 million, representing an increase of 22% to 32% year-over-year, and non-GAAP EPS of $0.51 to $0.55.